These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 27940758)

  • 1. Neonatal Morbidity After Maternal Use of Antidepressant Drugs During Pregnancy.
    Nörby U; Forsberg L; Wide K; Sjörs G; Winbladh B; Källén K
    Pediatrics; 2016 Nov; 138(5):. PubMed ID: 27940758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neonatal complications after maternal concomitant use of SSRI and other central nervous system active drugs during the second or third trimester of pregnancy.
    Källén B; Reis M
    J Clin Psychopharmacol; 2012 Oct; 32(5):608-14. PubMed ID: 22926593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal adaptation in infants prenatally exposed to antidepressants--clinical monitoring using Neonatal Abstinence Score.
    Forsberg L; Navér L; Gustafsson LL; Wide K
    PLoS One; 2014; 9(11):e111327. PubMed ID: 25365553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neonate characteristics after maternal use of antidepressants in late pregnancy.
    Källén B
    Arch Pediatr Adolesc Med; 2004 Apr; 158(4):312-6. PubMed ID: 15066868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal exposure to antidepressants and persistent pulmonary hypertension of the newborn: systematic review and meta-analysis.
    Grigoriadis S; Vonderporten EH; Mamisashvili L; Tomlinson G; Dennis CL; Koren G; Steiner M; Mousmanis P; Cheung A; Ross LE
    BMJ; 2014 Jan; 348():f6932. PubMed ID: 24429387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perinatal Outcomes After Treatment With ADHD Medication During Pregnancy.
    Nörby U; Winbladh B; Källén K
    Pediatrics; 2017 Dec; 140(6):. PubMed ID: 29127207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: population based cohort study from the five Nordic countries.
    Kieler H; Artama M; Engeland A; Ericsson O; Furu K; Gissler M; Nielsen RB; Nørgaard M; Stephansson O; Valdimarsdottir U; Zoega H; Haglund B
    BMJ; 2012 Jan; 344():d8012. PubMed ID: 22240235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal treatment with selective serotonin reuptake inhibitors during pregnancy and delayed neonatal adaptation: a population-based cohort study.
    Cornet MC; Wu YW; Forquer H; Avalos LA; Sriram A; Scheffler AW; Newman TB; Kuzniewicz MW
    Arch Dis Child Fetal Neonatal Ed; 2024 Apr; 109(3):294-300. PubMed ID: 38071585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delivery outcome in relation to maternal use of some recently introduced antidepressants.
    Lennestål R; Källén B
    J Clin Psychopharmacol; 2007 Dec; 27(6):607-13. PubMed ID: 18004128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antidepressant use late in pregnancy and risk of persistent pulmonary hypertension of the newborn.
    Huybrechts KF; Bateman BT; Palmsten K; Desai RJ; Patorno E; Gopalakrishnan C; Levin R; Mogun H; Hernandez-Diaz S
    JAMA; 2015 Jun; 313(21):2142-51. PubMed ID: 26034955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early morbidity and mortality following in utero exposure to selective serotonin reuptake inhibitors: a population-based study in Western Australia.
    Colvin L; Slack-Smith L; Stanley FJ; Bower C
    CNS Drugs; 2012 Jul; 26(7):e1-14. PubMed ID: 22712699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of Poor Neonatal Adaptation Syndrome Among Infants Exposed to Second-Generation Atypical Antipsychotics Compared to Antidepressants: Results From the National Pregnancy Registry for Psychiatric Medications.
    Viguera AC; McElheny SA; Caplin PS; Kobylski LA; Rossa ET; Young AV; Gaccione P; Góez-Mogollón L; Freeman MP; Cohen LS
    J Clin Psychiatry; 2023 Jan; 84(1):. PubMed ID: 36602927
    [No Abstract]   [Full Text] [Related]  

  • 13. Neonatal and childhood neurodevelopmental, health and educational outcomes of children exposed to antidepressants and maternal depression during pregnancy: protocol for a retrospective population-based cohort study using linked administrative data.
    Singal D; Brownell M; Chateau D; Ruth C; Katz LY
    BMJ Open; 2016 Nov; 6(11):e013293. PubMed ID: 27899401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of preeclampsia after gestational exposure to selective serotonin reuptake inhibitors and other antidepressants: A study from The Norwegian Mother and Child Cohort Study.
    Lupattelli A; Wood M; Lapane K; Spigset O; Nordeng H
    Pharmacoepidemiol Drug Saf; 2017 Oct; 26(10):1266-1276. PubMed ID: 28815791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidepressant medication use and risk of persistent pulmonary hypertension of the newborn.
    Andrade SE; McPhillips H; Loren D; Raebel MA; Lane K; Livingston J; Boudreau DM; Smith DH; Davis RL; Willy ME; Platt R
    Pharmacoepidemiol Drug Saf; 2009 Mar; 18(3):246-52. PubMed ID: 19148882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective Serotonin Reuptake Inhibitors and Persistent Pulmonary Hypertension of the Newborn: An Update Meta-Analysis.
    Ng QX; Venkatanarayanan N; Ho CYX; Sim WS; Lim DY; Yeo WS
    J Womens Health (Larchmt); 2019 Mar; 28(3):331-338. PubMed ID: 30407100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data.
    Reis M; Källén B
    Psychol Med; 2010 Oct; 40(10):1723-33. PubMed ID: 20047705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective serotonin reuptake inhibitor exposure in utero and pregnancy outcomes.
    Lund N; Pedersen LH; Henriksen TB
    Arch Pediatr Adolesc Med; 2009 Oct; 163(10):949-54. PubMed ID: 19805715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neonatal outcomes after late-gestation exposure to selective serotonin reuptake inhibitors.
    Grzeskowiak LE; Gilbert AL; Morrison JL
    J Clin Psychopharmacol; 2012 Oct; 32(5):615-21. PubMed ID: 22926594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective serotonin reuptake inhibitors during pregnancy and risk of stillbirth and infant mortality.
    Stephansson O; Kieler H; Haglund B; Artama M; Engeland A; Furu K; Gissler M; Nørgaard M; Nielsen RB; Zoega H; Valdimarsdóttir U
    JAMA; 2013 Jan; 309(1):48-54. PubMed ID: 23280224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.